Utama › Kanser Endometrium › California › San Diego
Kajian klinikal Kanser Endometrium di San Diego, CA
16 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi dalam dan sekitar San Diego (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- UC San Diego Medical Center - Hillcrest, San Diego
- Sharp Memorial Hospital, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi jauh
DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
- Research Site, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- University of California, San Diego, La Jolla · 11 mi jauh
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- Scripps Health, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Mengambil pesertaFasa 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi jauh
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Mengambil pesertaFasa 3
- Research Site, La Jolla · 11 mi jauh
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Mengambil pesertaFasa 1
- UC San Diego Moores Cancer Center, San Diego
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Mengambil pesertaFasa 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Mengambil pesertaFasa 3
- Research Site, La Jolla · 11 mi jauh
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Investigative Site #101, San Diego
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Mengambil pesertaFasa 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, La Jolla · 11 mi jauh
A Beta-only IL-2 ImmunoTherapY Study
Mengambil pesertaFasa 1/2
- Sharp Memorial Hospital, San Diego
Kajian Kanser Endometrium di bandar lain
- Houston, TX68 kajian
- New York City, NY52 kajian
- Boston, MA50 kajian
- Arlington, VA39 kajian
- Nashville, TN38 kajian
- Los Angeles, CA34 kajian
- St. Louis, MO29 kajian
- Philadelphia, PA28 kajian
- San Antonio, TX27 kajian
- Columbus, OH25 kajian
- Oklahoma City, OK25 kajian
- Chicago, IL25 kajian
Kajian lain di San Diego
- Kanser Paru-paru Bukan Sel Kecil48 kajian
- Kanser Payudara41 kajian
- Kanser (semua jenis)32 kajian
- Kanser Prostat31 kajian
- Kanser Metastatik30 kajian
- Kanser Kolorektal25 kajian
- Kanser Ovari24 kajian
- Kanser Pankreas24 kajian
- Kanser Paru-paru23 kajian
- Obesiti23 kajian
- Kegagalan Jantung23 kajian
- Depresi21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.